Skip to Content

Codeprex FDA Approval History

FDA Approved: Yes (Discontinued) (First approved June 21, 2004)
Brand name: Codeprex
Generic name: chlorpheniramine polistirex and codeine polistirex
Dosage form: Extended Release Suspension
Company: Lannett Company, Inc.
Treatment for: Cough

Marketing Status: Discontinued

Codeprex (chlorpheniramine polistirex and codeine polistirex) is an antihistamine and cough suppressant combination for the treatment of cough.

Development Timeline for Codeprex

Jun 21, 2004Approval Codeprex Celltech Group plc - Treatment for Cough

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.